论文部分内容阅读
目的:对急诊ICU中急性心衰合并呼吸衰竭应用无创呼吸机的临床价值进行讨论分析。方法:选取2016年9月至2017年2月我院收治的60例急性心衰合并呼吸衰竭的患者作为此次研究对象,随机分为对照组和治疗组,对照组患者实施常规治疗,治疗组患者实施无创呼吸机治疗,对两组患者的治疗效果进行比较。结果:(1)两组患者经过治疗后,治疗组患者的治疗总有效率93.3%明显高于对照组患者73.3%,数据差异具有统计学意义(P<0.05)。(2)两组患者经过治疗后,对照组患者不良反应发生率33.3%明显高于治疗组患者10.0%,数据差异具有统计学意义(P<0.05)。结论:急诊ICU中急性心衰合并呼吸衰竭应用无创呼吸机有着重要的临床价值,无创呼吸机具有效果好、安全性高的优势,值得在临床中广泛推广和使用。
Objective: To discuss and analyze the clinical value of non-invasive ventilator in acute ICU with acute heart failure and respiratory failure. Methods: Sixty patients with acute heart failure complicated with respiratory failure admitted to our hospital from September 2016 to February 2017 were randomly divided into control group and treatment group. Patients in control group were treated with conventional therapy. The treatment group Patients were treated with noninvasive ventilator, and the treatment effect was compared between the two groups. Results: (1) After treatment, the total effective rate of treatment group was 93.3%, which was significantly higher than that of control group (73.3%). The difference was statistically significant (P <0.05). (2) After treatment, the incidence of adverse reactions in the control group was significantly higher than that in the treatment group (33.3% vs 10.0%, P <0.05). Conclusion: Application of noninvasive ventilator in acute ICU with acute heart failure and respiratory failure has important clinical value. Noninvasive ventilator has the advantages of good effect and high safety. It is worth widely used and widely used in clinical practice.